MetaCap

Artelo Biosciences (ARTL) vs Capstone (CAPS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Capstone is the larger company by market cap ($1.3 million vs $1.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARTL-59.24%CAPS+927.84%
+2019%+930%-158%
Oct 7, 20261 yearNov 20, 2026
ARTL-57.36%CAPS+949.56%
+1880%+865%-150%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARTL versus CAPS key metrics
MetricARTLCAPS
Share price$1.39$1.44
Market cap$1.30M$1.35M
1-day change-4.14%-9.15%
EPS (TTM)$-20.56$-89.68
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$46.88M
Revenue growth (YoY)—+4.47%
Net income (latest FY)$-12.88M$-21.23M
Gross margin—23.02%
Operating margin—-23.43%
Net margin—-45.28%
52-week high$179.19$28.50
52-week low$1.30$1.42
Distance from 52-week high-99.22%-94.95%
Analyst consensus—none
Avg. price target upside—+108.33%
Average volume476.69K153.70K
Shares outstanding937.18K935.38K
Employees793
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Artelo Biosciences

ARTL stock →

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees

ARTL vs CAPS FAQ

Which is bigger, Artelo Biosciences or Capstone?

Capstone (CAPS) is larger, with a market capitalization of $1.35M compared with $1.30M for Artelo Biosciences (ARTL).

Are Artelo Biosciences and Capstone in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons